Related Experiment Video
Updated: Apr 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination]
Irene Rivero Calle1, Carmen Rodriguez-Tenreiro Sánchez1, Federico Martinón-Torres1
1Pediatría Clínica, Infectológica y Traslacional. Departamento de Pediatría, Hospital Clínico Universitario de Santiago, Unidad de Investigación en Vacunas, GENVIP, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, La Coruña, España.
Abstract:
N. meningitidis is a major cause of meningitis and septicemia and a major public health problem in many countries. The disease, that can be fulminant, has a high mortality and may cause serious sequelae, even in cases of apparently optimal medical treatment. Chemoprophylaxis may prevent secondary cases among those in close contact with the ill, but, since secondary cases represent only 1%-2% of all meningococcal disease, chemoprophylaxis has a small impact when fighting most of endemic and epidemic forms. Given that al least 5% -15% of children and young adults are carriers, the fight against meningococcal disease based on chemotherapeutic elimination of nasopharyngeal colonization is virtually impossible. Therefore, immunization is the only rational way to combat this disease.
Insights
Meningococcal disease, caused by Neisseria meningitidis, presents a significant public health challenge. Immunization is the most effective strategy against this potentially fatal illness, as chemoprophylaxis and eliminating carriers are impractical.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Neisseria meningitidis (N. meningitidis) is a primary cause of meningitis and septicemia globally.
- Meningococcal disease is characterized by high mortality and severe sequelae, even with advanced medical care.
- Current control strategies like chemoprophylaxis have limited impact on overall disease burden.
Purpose of the Study:
- To evaluate the effectiveness of different strategies for controlling meningococcal disease.
- To highlight the limitations of chemoprophylaxis and carrier elimination.
- To advocate for immunization as the primary method for disease prevention.
Main Methods:
- Review of existing literature on N. meningitidis epidemiology and control.
- Analysis of the impact of chemoprophylaxis on secondary cases.
- Assessment of the feasibility of eliminating nasopharyngeal carriers.
Main Results:
- Secondary cases account for only 1%-2% of all meningococcal disease cases.
- Chemoprophylaxis has a minimal effect on endemic and epidemic forms of the disease.
- Nasopharyngeal carriage rates of 5%-15% in children and young adults make carrier elimination unfeasible.
Conclusions:
- Chemotherapeutic elimination of nasopharyngeal colonization is not a viable strategy.
- Immunization remains the only rational and effective approach to combat meningococcal disease.
- Vaccination is crucial for reducing the incidence and impact of meningitis and septicemia.
More Related Videos
Related Concept Videos
Viral Meningitis
Vaccinations
Infectious Diseases and Their Occurrence
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Microorganisms in Medicine and Therapeutics

